Cargando…
BRAF(V600E)-induced, tumor intrinsic PD-L1 can regulate chemotherapy-induced apoptosis in human colon cancer cells and in tumor xenografts
Programmed death ligand 1 (PD-L1) is an immune checkpoint protein, however, emerging data suggest that tumor cell PD-L1 may regulate immune-independent and intrinsic cellular functions. We demonstrate regulation of PD-L1 by oncogenic BRAF(V600E) and investigated its ability to influence apoptotic su...
Autores principales: | Feng, Daofu, Qin, Bo, Pal, Krishnendu, Sun, Lei, Dutta, Shamit, Dong, Haidong, Liu, Xin, Mukhopadhyay, Debabrata, Huang, Shengbing, Sinicrope, Frank A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6786951/ https://www.ncbi.nlm.nih.gov/pubmed/31406255 http://dx.doi.org/10.1038/s41388-019-0919-y |
Ejemplares similares
-
Co-delivery of everolimus and vinorelbine via a tumor-targeted liposomal formulation inhibits tumor growth and metastasis in RCC
por: Pal, Krishnendu, et al.
Publicado: (2019) -
Synchronous inhibition of mTOR and VEGF/NRP1 axis impedes tumor growth and metastasis in renal cancer
por: Pal, Krishnendu, et al.
Publicado: (2019) -
Targeted Dual Intervention-Oriented Drug-Encapsulated (DIODE) Nanoformulations for Improved Treatment of Pancreatic Cancer
por: Madamsetty, Vijay Sagar, et al.
Publicado: (2020) -
Tissue architecture delineates field cancerization in BRAF(V600E)-induced tumor development
por: Schoultz, Elin, et al.
Publicado: (2021) -
Tissue-Agnostic Activity of BRAF plus MEK Inhibitor in BRAF V600–Mutant Tumors
por: Adashek, Jacob J., et al.
Publicado: (2022)